174 related articles for article (PubMed ID: 1535533)
1. Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
Lisovoski F; Haby C; Borrelli E; Schleef C; Revel MO; Hindelang C; Zwiller J
Brain Res Bull; 1992 May; 28(5):697-701. PubMed ID: 1535533
[TBL] [Abstract][Full Text] [Related]
2. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
[TBL] [Abstract][Full Text] [Related]
3. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
4. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
[TBL] [Abstract][Full Text] [Related]
5. A 6-hydroxydopamine-induced selective parkinsonian rat model.
Perese DA; Ulman J; Viola J; Ewing SE; Bankiewicz KS
Brain Res; 1989 Aug; 494(2):285-93. PubMed ID: 2528389
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
7. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
[TBL] [Abstract][Full Text] [Related]
8. Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine.
Chen JF; Qin ZH; Szele F; Bai G; Weiss B
Neuropharmacology; 1991 Sep; 30(9):927-41. PubMed ID: 1833662
[TBL] [Abstract][Full Text] [Related]
9. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
[TBL] [Abstract][Full Text] [Related]
10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
11. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
Rioux L; Gaudin DP; Gagnon C; Di Paolo T; Bédard PJ
Neuroscience; 1991; 44(1):75-83. PubMed ID: 1770999
[TBL] [Abstract][Full Text] [Related]
12. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism.
Friehs GM; Parker RG; He LS; Haines SJ; Turner DA; Ebner TJ
J Neural Transplant Plast; 1991; 2(2):141-56. PubMed ID: 1684115
[TBL] [Abstract][Full Text] [Related]
13. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
Hefti F; Melamed E; Wurtman RJ
Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003
[TBL] [Abstract][Full Text] [Related]
14. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat.
Cadet JL; Zhu SM
Brain Res; 1992 Nov; 595(2):316-26. PubMed ID: 1467973
[TBL] [Abstract][Full Text] [Related]
15. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
16. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms.
Robertson GS; Robertson HA
J Neurosci; 1989 Sep; 9(9):3326-31. PubMed ID: 2795165
[TBL] [Abstract][Full Text] [Related]
17. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
19. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
Melamed E; Hefti F; Wurtman RJ
Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
